NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock
2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | 6.26M | 20.17M | -3.91M | -3.82M | 4.24M | |||
Depreciation Amortization | 21.30M | 19.39M | 9.19M | 6.27M | 4.73M | |||
Change In Working Capital | -39.65M | -83.80M | -62.28M | -52.74M | -35.66M | |||
Interest Paid | 24.72M | 18.05M | N/A | N/A | N/A | |||
Other non cash items | 53.78M | 46.82M | 39.49M | 44.09M | 38.12M | |||
OPERATING CASH FLOW | 41.68M | 2.59M | -17.52M | -6.21M | 11.42M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -22.78M | -22.56M | -9.00M | -13.92M | -4.50M | |||
Other Investing Activity | -5.95M | -3.16M | 11.90M | 5.61M | -17.71M | |||
INVESTING CASH FLOW | -28.73M | -25.73M | 2.90M | -8.31M | -22.21M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | 15.58M | 54.45M | 15.55M | 11.89M | 33.56M | |||
Stock Issued/Repurchased | -734.39K | -3.00M | 0.00 | -4.53M | -30.00K | |||
Dividend Paid | -174.80K | -452.13K | N/A | N/A | N/A | |||
Other Financing Activity | -24.72M | -18.05M | -720.00K | N/A | 0.00 | |||
FINANCING CASH FLOW | -10.06M | 32.95M | 14.82M | 7.36M | 33.53M | |||
Exchange Rate Effect | -6.56M | 4.94M | 6.84M | 6.27M | 1.52M | |||
CHANGE IN CASH | -3.66M | 14.76M | 7.04M | -890.00K | 24.26M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | 41.68M | 2.59M | -17.52M | -6.21M | 11.42M | |||
Capital Expenditure | -22.78M | -22.56M | -9.00M | -13.92M | -4.50M | |||
FREE CASH FLOW | 18.90M | -19.97M | -26.52M | -20.13M | 6.92M |
All data in USD